GSK ($GSK) Insider Trading & Smart Money Activity

GSK plc · Drug Manufacturers - General · Latest filing May 15, 2026

GSK plc ($GSK) has 5 13F position changes on file.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 5
Analyst ratings on file: 0

GSK insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	2 / 3
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All GSK insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	1W	1M	Story
May 15, 2026	13F	Holocene Advisors	Reduced	-2.60M sh	$289.28M	+3.4%	+5.1%	—
May 14, 2026	13F	Dodge & Cox	Reduced	-9.85M sh	$3.10B	+2.0%	+3.4%	—
May 14, 2026	13F	Dodge & Cox	Reduced	-9.85M sh	$3.10B	+2.0%	+3.4%	Read
May 5, 2026	13F	Fisher Asset Management	Added	+1.33M sh	$1.82B	+1.0%	+2.7%	—
May 5, 2026	13F	Fisher Asset Management	Added	+1.33M sh	$1.82B	+1.0%	+2.7%	—

1W / 1M / 6M = how GSK moved from the trade or filing date.

Institutions moving GSK (13F)

Frequently asked questions

Which institutions changed their GSK positions?

Recent 13F filers moving the stock include Dodge & Cox, Fisher Asset Management and Holocene Advisors.

Other drug manufacturers - general stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text